UBS O'Connor’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $668K | Buy |
+6,400
| New | +$668K | 0.03% | 234 |
|
|
2024
Q4 | – | Sell |
-15,666
| Closed | -$1.41M | – | 359 |
|
|
2024
Q3 | $1.41M | Buy |
15,666
+548
| +4% | +$49.2K | 0.03% | 231 |
|
|
2024
Q2 | $1.22M | Buy |
15,118
+6,200
| +70% | +$499K | 0.03% | 267 |
|
|
2024
Q1 | $712K | Sell |
8,918
-3,004
| -25% | -$240K | 0.02% | 304 |
|
|
2023
Q4 | $949K | Sell |
11,922
-13,813
| -54% | -$1.1M | 0.03% | 271 |
|
|
2023
Q3 | $1.8M | Hold |
25,735
| – | – | 0.03% | 259 |
|
|
2023
Q2 | $1.85M | Buy |
25,735
+3,169
| +14% | +$228K | 0.04% | 311 |
|
|
2023
Q1 | $1.39M | Buy |
+22,566
| New | +$1.39M | 0.03% | 373 |
|
|
2022
Q4 | – | Sell |
-5,000
| Closed | -$223K | – | 45 |
|
|
2022
Q3 | $223K | Sell |
5,000
-23,026
| -82% | -$1.03M | ﹤0.01% | 806 |
|
|
2022
Q2 | $1.07M | Buy |
+28,026
| New | +$1.07M | 0.01% | 740 |
|